Delivery Order SPE2DB20D3101-SPE2DB23FQXE3

Award Date 12/12/22
Potential Completion Date 12/13/22
Potential Value $1.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,624.23, is for the supply of Veltassa 8.4 GM Powder Packets. The contract has a firm fixed price pricing type and does not utilize any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is for the delivery of Veltassa 8.4 GM powder packets. The $1,547.26 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) and has a completion date of March 22, 2022. Amerisourcebergen is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Veltassa 8.4 GM Powder Packet 30S, a pharmaceutical product. The contract has a ceiling value of $1,211.08 and a period of performance through August 27, 2024. It is a firm fixed-price contract. AmerisourceBergen, a major pharmaceutical distributor, will deliver these medical supplies to support military treatment facilities and federal healthcare programs. This delivery...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Veltassa 8.4 GM powder packets. The contract, valued at $6,103.92, was awarded on September 14, 2021 by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. This contract is a delivery order, with a firm fixed price pricing type. It does not have a set-aside designation, indicating open competition....
This federal contract award is for the delivery of Veltassa 8.4 GM powder packets to the Defense Logistics Agency (DLA). The $1,839.24 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 8, 2021. The contract has a completion date of September 9, 2021 and was not set aside for any specific business type. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the delivery of Veltassa 8.4 GM powder packets, a specialty pharmaceutical product, to support military treatment programs and facilities. The delivery order has a ceiling value of $1,291.10 and a period of performance through April 4, 2024. Amerisourcebergen Drug Corp holds an indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,358.10 firm fixed-price delivery order is for the supply of Veltassa 8.4 GM powder packets, a specialty pharmaceutical product. The contract has an ultimate completion date of January 31, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $18,521.16 firm fixed price contract is for the supply of Veltassa 8.4 GM Powder Packet 30S, a pharmaceutical product. The contract has an ultimate completion date of October 8, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medical commodities,...
This federal contract award, with ID SPE2DB20D3505|SPE2DB24FU0F1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Veltassa 8.4 GM powder packets, a pharmaceutical product, with a total ceiling value of $1,936.65 and a completion date of April 2, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Veltassa 8.4 GM powder packets. The contract has a ceiling value of $7,740.07 and a performance period through March 14, 2025. It is a firm-fixed-price contract type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FQXE3
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Veltassa 8.4 GM powder packets. The $1,082.84 firm-fixed-price contract has a completion date of December 13, 2022 and is not associated with a set-aside program. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation for the provision of a wide range of pharmaceutical products and medical supplies to support federal healthcare programs, particularly within the Department of Defense and Department of Veterans Affairs. These IDCs, valued at up to $999,999,999.00 and $750,000.00 respectively, enable efficient and comprehensive procurement of essential medications, medical devices, and other critical healthcare commodities for military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 1:28 PM